stock

Amgen, Inc. (AMGN)

0
September 3rd, 2020

Share

Stay up to date

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Financial Statements

Key Info

  • Industry: Biotechnology
  • Sector: Health Technology
  • CEO Name: Robert A. Bradway

Key Statistics

  • Stock Price: $258.12
  • Dividend Yield: 2.4%
  • Market Capitalization: $151,179,335,280
  • Shares Outstanding: 585,694,000
  • Number of Employees: 23,400
  • Trailing 12-Month EPS: $12.32
  • Trailing 12-Month DPS: $6.1
  • Payout Ratio: 49.5%

Important Dates

  • Next Earnings Date: 2020-11-03
  • Next Ex-Dividend Date: 2020-08-14

Price Trends

  • Current Stock Price: $258.12
  • 52-week high: $264.97
  • 52-week low: $177.05
  • 200-day moving average: $230.85
  • 50-day moving average: $247.01

Performance

  • 1-Month Price Return: 4.3%
  • 3-Month Price Return: 16.8%
  • 6-Month Price Return: 26.3%
  • 1-Year Price Return: 25.6%
  • 2-Year Price Return: 25.4%
  • 5-Year Price Return: 43.8%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

September 3rd, 2020